Kamran, Mr. Waseem
Early, advanced and recurrent malignancies of uterus, ovaries, fallopian tubes, cervix and vulva; fertility preserving procedures; ultra-radical cytoreductive surgery in advanced cancers; sentinel as well as therapeutic lymph node dissection; robotic surgery.
Mr Waseem Kamran is a certified surgical gynaecological oncologist and cytoreductive surgeon at St James’s as well as Blackrock clinic. Following his specialist training in general Obstetrics and Gynaecology from London, he gained certification in urogynaecology & advanced pelvic reconstructive surgery from Kings College hospital, London. He undertook his formal advanced minimally invasive surgery (key hole) training at the minimal access therapy training unit (MATTU) – one of the leading institutes for laparoscopic surgery in the UK and worldwide – which culminated in a postgraduate diploma in advanced laparoscopic surgery.
Mr Kamran undertook an RCOG approved fellowship in surgical management of gynaecological cancer. During this three years long clinical fellowship, he received an unparalleled multi-organ surgical training in the management of gynaecological cancers.
As well as being able to surgically deal with all kinds of simple and complex benign gynaecological conditions, Mr Kamran is passionate to use the most innovative surgical techniques for women with early, advanced and recurrent malignancies of uterus, ovaries, fallopian tubes, cervix and vulva. He offers some of the latest cutting edge surgical treatments to his cancer patients including fertility preserving procedures, ultra-radical cytoreductive surgery in advanced cancers, sentinel as well as therapeutic lymph node dissection and robotic surgery which enables more patients with high body mass index to have key hole surgery resulting in better recovery and improved cosmetic outcomes.
Over the last 5 years, Mr Kamran has pioneered the use of laparoscopic surgery in the field of gynaecological oncology in Ireland and has dedicated much of his time to expand and incorporate new surgical techniques in the surgical management of ovarian cancer. He is one of a handful of oncology surgeons in Europe who are proficient in performing such extensive multi-organ cytoreductive surgeries for gynaecological malignancies.
He has published in peer-reviewed international journals and has presented his work in international conferences. His laboratory based research is into HE4 ovarian cancer biomarker and its potential role in the follow up of ovarian cancer.